Literature DB >> 15807871

Novel missense mutations, GCC [Ala306]- > GTC [Val] and ACG [Thr318]- > CCG [Pro], in the CYP11B1 gene cause steroid 11beta-hydroxylase deficiency in the Chinese.

Hsien-Hsiung Lee1, Ging-Shing Won, Hsiang-Tai Chao, Yann-Jinn Lee, Bon-Chu Chung.   

Abstract

OBJECTIVE: Steroid 11beta-hydroxylase (CYP11B1) deficiency, an autosomal recessive inherited disease, accounts for 5-8% of congenital adrenal hyperplasia (CAH). It is mainly caused by mutations of nucleotide substitutions in the coding region. PATIENTS AND METHODS: The study reports on a 9-year-old Chinese boy who presented with a bone age of 16 years, an enlarged penis, an accelerated growth rate since early childhood and hypertension (160-170/100-110 mmHg) for 3 years. Because it shares 95% sequence homology with aldosterone synthetase (CYP11B2), we developed gene-specific primers for differential PCR amplification of the CYP11B1 gene. The secondary PCR products of nine exons of the CYP11B1 gene were then subjected to single-strand conformation polymorphism (SSCP) analysis and DNA sequencing. The serum hormone levels were also determined.
RESULTS: We found that the boy diagnosed with CAH due to 11beta-hydroxylase deficiency carried mutations of A306V (GCC- > GTC) and T318P (ACG- > CCG) in two respective chromosomes. The hormone assay showed that the 11-deoxycortisol level was higher (667 nmol/l) than normal and was further increased after ACTH stimulation (1206 nmol/l).
CONCLUSIONS: These two mutations have not previously been described in the CYP11B1 gene. The discovery of these two novel mutations increases our knowledge of CAH caused by 11beta-hydroxylase deficiency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15807871     DOI: 10.1111/j.1365-2265.2005.02234.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations.

Authors:  Soara Menabò; Seher Polat; Lilia Baldazzi; Alexandra E Kulle; Paul-Martin Holterhus; Joachim Grötzinger; Flaminia Fanelli; Antonio Balsamo; Felix G Riepe
Journal:  Eur J Hum Genet       Date:  2013-09-11       Impact factor: 4.246

2.  Improving the diagnosis of 11β-hydroxylase deficiency using home-made MLPA probes: identification of a novel chimeric CYP11B2/CYP11B1 gene in a Sicilian patient.

Authors:  S Menabò; S Boccassini; A Gambineri; A Balsamo; R Pasquali; O Prontera; L Mazzanti; L Baldazzi
Journal:  J Endocrinol Invest       Date:  2015-08-18       Impact factor: 4.256

3.  Two novel mutations in CYP11B1 and modeling the consequent alterations of the translated protein in classic congenital adrenal hyperplasia patients.

Authors:  Mohammad Reza Abbaszadegan; Soolmaz Hassani; Rahim Vakili; Mohammad Reza Saberi; Alireza Baradaran-Heravi; Azadeh A'rabi; Mahin Hashemipour; Maryam Razzaghi-Azar; Omeed Moaven; Ali Baratian; Mitra Ahadian; Fatemeh Keify; Nathalie Meurice
Journal:  Endocrine       Date:  2013-01-24       Impact factor: 3.633

4.  Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11{beta}-hydroxylase deficiency.

Authors:  Silvia Parajes; Lourdes Loidi; Nicole Reisch; Vivek Dhir; Ian T Rose; Rainer Hampel; Marcus Quinkler; Gerard S Conway; Lidia Castro-Feijóo; David Araujo-Vilar; Manuel Pombo; Fernando Dominguez; Emma L Williams; Trevor R Cole; Jeremy M Kirk; Elke Kaminsky; Gill Rumsby; Wiebke Arlt; Nils Krone
Journal:  J Clin Endocrinol Metab       Date:  2010-01-20       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.